MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,212 | -58.5% | 10,300 | -34.4% | 0.03% | -49.2% |
| Q2 2023 | $3,626,700 | +283.9% | 15,700 | +302.6% | 0.06% | +364.3% |
| Q1 2023 | $944,814 | -16.5% | 3,900 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,131,975 | -78.2% | 3,900 | -92.6% | 0.01% | -75.0% |
| Q1 2022 | $5,181,000 | +15.8% | 52,800 | 0.0% | 0.06% | +16.7% |
| Q4 2021 | $4,474,000 | +6.2% | 52,800 | 0.0% | 0.05% | +14.3% |
| Q3 2021 | $4,213,000 | +53.9% | 52,800 | +87.9% | 0.04% | +50.0% |
| Q2 2021 | $2,737,000 | – | 28,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |